Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancer
US-2020325228-A1 · Oct 15, 2020 · US
Merck Sharpe & Dohme Corp was listed as an assignee on 2 patent publications in 2020.
| Metric | Value |
|---|---|
| Company | Merck Sharpe & Dohme Corp |
| Year | 2020 |
| Patents | 2 |
Representative publications for Merck Sharpe & Dohme Corp in 2020.
Most common classification codes for Merck Sharpe & Dohme Corp in 2020.
| CPC | Patents |
|---|---|
| A61K2039/505 | 2 |
| A61K2039/545 | 2 |
| A61K2300/00 | 2 |
| A61K31/4439 | 2 |
| A61K39/39558 | 2 |
Navigate to parent entity pages.